Immunoreactive trypsinogen in healthy newborns and infants with cystic fibrosis.

Fingerhut, Ralph; Rueegg, Corina Silvia; Imahorn, Orell; Pedersen, Eva Sophie Lunde; Kuehni, Claudia Elisabeth; Gallati, Sabina; Regamey, Nicolas; Barben, Jürg (2023). Immunoreactive trypsinogen in healthy newborns and infants with cystic fibrosis. Archives of disease in childhood. Fetal and neonatal edition, 108(2), pp. 176-181. BMJ Publishing Group 10.1136/archdischild-2021-323549

Text Fingerhut_ArchDisChildFetalNeonatalEd_2023.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Authors hold Copyright Download (2MB) | Request a copy

OBJECTIVE

Newborn screening (NBS) for cystic fibrosis (CF) was introduced in Switzerland in 2011 based on an immunoreactive trypsinogen (IRT)-DNA-IRT protocol. CF diagnosis was confirmed by sweat test and/or genetics but remained inconclusive for some newborns (cystic fibrosis transmembrane conductance regulator related metabolic syndrome (CRMS)/CF screen positive, inconclusive diagnosis (CFSPID)). We aimed to (1) Describe IRT levels in healthy newborns in the first year of life and by gestational age (GA), and (2) Compare IRT at two time points between healthy newborns and newborns with CF and CRMS/CFSPID.

DESIGN

Retrospective study.

SETTING

National NBS database.

PATIENTS

All children with an IRT measurement by heel prick test from 2011 to 2019.

INTERVENTIONS

None.

MAIN OUTCOME MEASURES

IRT values were extracted from the National NBS Laboratory, and clinical characteristics of positively screened children from the CF-NBS database. Second IRT assessment in positively screened children was usually performed after 18-24 days. We calculated internal IRT Z-Scores and multiples of the median to compare our results across different laboratory tools.

RESULTS

Among 815 899 children; 232 were diagnosed with CF, of whom 36 had meconium ileus (MI); 27 had CRMS/CFSPID. Among all samples analysed, mean IRT Z-Scores were higher for newborns with GA <33 weeks and ≥43 weeks (all Z-Scores >0.11) compared with term babies (all Z-Scores ≤0.06). Repeated IRT Z-Scores after a median (IQR) of 19 (17-22) days remained high for infants with CF with or without MI but decreased for infants with CRMS/CFSPID.

CONCLUSIONS

Measurement of a second IRT value can help distinguish between children with CRMS/CFSPID and CF, early in life.

Interest & Impact

Downloads

2 since deposited on 10 Nov 2022
2 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item